Skip to main content

Table 1 Demographic characteristics of the patients

From: Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China

 

No. of patients

Total No. of patients

32

  < 5 years old

13

  ≥ 5 years old

19

Sex

 Male

19

 Female

13

 

Mean ± SD

Mean age (years)

5 3

 Mean age of diagnosis (months)

14 15

 Mean age of first blood transfusion (months)

15 15

 Mean age of the start of chelating therapy (years)

3 2

 

No. of patients

Chelating regulatory (≥1 chelating agent)

 Regular

19

 Only Deferoxamine

0

 Only Defriprone

6

 Only Deferasirox

6

 Deferoxamine+Defriprone

4

 Defriprone+Deferasirox

2

 Not regular

1

 Never

12

No. of patients with oral supplementations (Calcium or Vitamin D)

 Regular

12

 Occasional

5

 Never

15

  1. Children with confirmed β-thalassemia major who visited the Department of Hematology and Oncology Department at Shenzhen Children’s Hospital for regular blood transfusions between January and June 2018 were recruited for the study. The patients’ demographic characteristics were reviewed retrospectively